{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:37:22Z","timestamp":1776825442366,"version":"3.51.2"},"reference-count":161,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/hwmb1163","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T03:39:01Z","timestamp":1714448341000},"page":"1482-1500","source":"Crossref","is-referenced-by-count":6,"title":["Controversial role of \u03b3\u03b4 T cells in colorectal cancer"],"prefix":"10.62347","volume":"14","author":[{"given":"Xianzhe","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","article-title":"Drug resistance and new therapies in colorectal cancer","volume":"24","author":"Van der Jeught","year":"2018","unstructured":"Van der Jeught K, Xu HC, Li YJ, Lu XB and Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 2018; 24: 3834-3848.","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","unstructured":"Johdi NA and Sukor NF. Colorectal cancer immunotherapy: options and strategies. Front Immunol 2020; 11: 1624.","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","unstructured":"Chen DS and Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017; 541: 321-330.","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","unstructured":"Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y, Sun Z, Zhang Y and Wang C. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer 2023; 22: 29.","journal-title":"Mol Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"NA","year":"2019","unstructured":"Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, Validire P, Ingels A, Cathelineau X, Fridman WH and Sautès-Fridman C. The clinical role of the TME in solid cancer. Br J Cancer 2019; 120: 45-53.","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.3390\/molecules25184292","article-title":"Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study","volume":"25","author":"Buhrmann","year":"2020","unstructured":"Buhrmann C, Shayan P, Brockmueller A and Shakibaei M. Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study. Molecules 2020; 25: 4292.","journal-title":"Molecules"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ags3.12362","article-title":"Investigation of colorectal cancer in accordance with consensus molecular subtype classification","volume":"4","author":"Sawayama","year":"2020","unstructured":"Sawayama H, Miyamoto Y, Ogawa K, Yoshida N and Baba H. Investigation of colorectal cancer in accordance with consensus molecular subtype classification. Ann Gastroenterol Surg 2020; 4: 528-539.","journal-title":"Ann Gastroenterol Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH and Diaz LA Jr. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 2019; 16: 361-375.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/iub.2461","article-title":"T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer","volume":"73","author":"Fathi","year":"2021","unstructured":"Fathi M, Pustokhina I, Kuznetsov SV, Khayrullin M, Hojjat-Farsangi M, Karpisheh V, Jalili A and Jadidi-Niaragh F. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. IUBMB Life 2021; 73: 726-738.","journal-title":"IUBMB Life"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/imr.12904","article-title":"Deciphering human γδ T cell response in cancer: lessons from tumor-infiltrating γδ T cells","volume":"298","author":"Presti E","year":"2020","unstructured":"Lo Presti E, Dieli F, Fourniè JJ and Meraviglia S. Deciphering human γδ T cell response in cancer: lessons from tumor-infiltrating γδ T cells. Immunol Rev 2020; 298: 153-164.","journal-title":"Immunol Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/cmi.2017.73","article-title":"Human regulatory γδT cells and their functional plasticity in the tumor microenvironment","volume":"15","author":"Chen","year":"2018","unstructured":"Chen H and He W. Human regulatory γδT cells and their functional plasticity in the tumor microenvironment. Cell Mol Immunol 2018; 15: 411-413.","journal-title":"Cell Mol Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/cells12131693","article-title":"Prognostic immune effector signature in adult acute lymphoblastic leukemia patients is dominated by γδ T cells","volume":"12","author":"Floch AC","year":"2023","unstructured":"Le Floch AC, Rouvière MS, Salem N, Ben Amara A, Orlanducci F, Vey N, Gorvel L, Chretien AS and Olive D. Prognostic immune effector signature in adult acute lymphoblastic leukemia patients is dominated by γδ T cells. Cells 2023; 12: 1693.","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3748\/wjg.v22.i13.3573","article-title":"Analysis of tumor-infiltrating gamma delta T cells in rectal cancer","volume":"22","author":"Rong","year":"2016","unstructured":"Rong L, Li K, Li R, Liu HM, Sun R and Liu XY. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer. World J Gastroenterol 2016; 22: 3573-3580.","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3389\/fimmu.2020.01600","article-title":"Immune effects of γδ T cells in colorectal cancer: a review","volume":"11","author":"Ma","year":"2020","unstructured":"Ma R, Yuan D, Guo Y, Yan R and Li K. Immune effects of γδ T cells in colorectal cancer: a review. Front Immunol 2020; 11: 1600.","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.canlet.2016.07.001","article-title":"Prospects for chimeric antigen receptor (CAR) γδ T cells: a potential game changer for adoptive T cell cancer immunotherapy","volume":"380","author":"Mirzaei","year":"2016","unstructured":"Mirzaei HR, Mirzaei H, Lee SY, Hadjati J and Till BG. Prospects for chimeric antigen receptor (CAR) γδ T cells: a potential game changer for adoptive T cell cancer immunotherapy. Cancer Lett 2016; 380: 413-423.","journal-title":"Cancer Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cvfa.2019.08.001","article-title":"Gamma delta T cell function in ruminants","volume":"35","author":"Guerra-Maupome M","year":"2019","unstructured":"Guerra-Maupome M, Slate JR and McGill JL. Gamma delta T cell function in ruminants. Vet Clin North Am Food Anim Pract 2019; 35: 453-469.","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.immuni.2010.10.014","article-title":"T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells","volume":"33","author":"Park","year":"2010","unstructured":"Park SG, Mathur R, Long M, Hosh N, Hao L, Hayden MS and Ghosh S. T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells. Immunity 2010; 33: 791-803.","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/ecco-jcc\/jjz015","article-title":"Characterization of γδ T cells in intestinal mucosa from patients with early-onset or long-standing inflammatory bowel disease and their correlation with clinical status","volume":"13","author":"Lo Presti","year":"2019","unstructured":"Lo Presti E, Di Mitri R, Mocciaro F, Di Stefano AB, Scibetta N, Unti E, Cicero G, Pecoraro G, Conte E, Dieli F and Meraviglia S. Characterization of γδ T cells in intestinal mucosa from patients with early-onset or long-standing inflammatory bowel disease and their correlation with clinical status. J Crohns Colitis 2019; 13: 873-883.","journal-title":"J Crohns Colitis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","unstructured":"Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang Z, Wang C, Zhang Z, Xia W, Chen Z, Wang K, Zhang T, Xu J, Han Y, Zhang T, Wu X, Wang J, Gong W, Zheng S, Qiu F, Yan J and Huang J. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014; 40: 785-800.","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Bilate AM, London M, Castro TBR, Mesin L, Bortolatto J, Kongthong S, Harnagel A, Victora GD and Mucida D. T cell receptor is required for differentiation, but not maintenance, of intestinal CD4(+) intraepithelial lymphocytes. Immunity 2020; 53: 1001-1014, e1020.","DOI":"10.1016\/j.immuni.2020.09.003"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41586-022-05259-y","article-title":"The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death","volume":"610","author":"Matsuzawa-Ishimoto","year":"2022","unstructured":"Matsuzawa-Ishimoto Y, Yao X, Koide A, Ueberheide BM, Axelrad JE, Reis BS, Parsa R, Neil JA, Devlin JC, Rudensky E, Dewan MZ, Cammer M, Blumberg RS, Ding Y, Ruggles KV, Mucida D, Koide S and Cadwell K. The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death. Nature 2022; 610: 547-554.","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Mikulak J, Oriolo F, Bruni E, Roberto A, Colombo FS, Villa A, Bosticardo M, Bortolomai I, Lo Presti E, Meraviglia S, Dieli F, Vetrano S, Danese S, Della Bella S, Carvello MM, Sacchi M, Cugini G, Colombo G, Klinger M, Spaggiari P, Roncalli M, Prinz I, Ravens S, di Lorenzo B, Marcenaro E, Silva-Santos B, Spinelli A and Mavilio D. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 2019; 4: e125884.","DOI":"10.1172\/jci.insight.125884"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sullivan ZA, Khoury-Hanold W, Lim J, Smillie C, Biton M, Reis BS, Zwick RK, Pope SD, Israni-Winger K, Parsa R, Philip NH, Rashed S, Palm N, Wang A, Mucida D, Regev A and Medzhitov R. γδ T cells regulate the intestinal response to nutrient sensing. Science 2021; 371: eaba8310.","DOI":"10.1126\/science.aba8310"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.4049\/jimmunol.0802705","article-title":"Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury","volume":"182","author":"AS","year":"2009","unstructured":"Ismail AS, Behrendt CL and Hooper LV. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol 2009; 182: 3047-3054.","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2021.02.023","article-title":"Augmented Th17-stimulating activity of BMDCs as a result of reciprocal interaction between γδ and dendritic cells","volume":"134","author":"Sun","year":"2021","unstructured":"Sun D, Ko MK, Shao H and Kaplan HJ. Augmented Th17-stimulating activity of BMDCs as a result of reciprocal interaction between γδ and dendritic cells. Mol Immunol 2021; 134: 13-24.","journal-title":"Mol Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41590-020-00848-3","article-title":"Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments","volume":"22","author":"Lopes","year":"2021","unstructured":"Lopes N, McIntyre C, Martin S, Raverdeau M, Sumaria N, Kohlgruber AC, Fiala GJ, Agudelo LZ, Dyck L, Kane H, Douglas A, Cunningham S, Prendeville H, Loftus R, Carmody C, Pierre P, Kellis M, Brenner M, Argüello RJ, Silva-Santos B, Pennington DJ and Lynch L. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Nat Immunol 2021; 22: 179-192.","journal-title":"Nat Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1349-7006.2001.tb01176.x","article-title":"Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gammadelta T lymphocyte-deficient mice","volume":"92","author":"Matsuda","year":"2001","unstructured":"Matsuda S, Kudoh S and Katayama S. Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gammadelta T lymphocyte-deficient mice. Jpn J Cancer Res 2001; 92: 880-885.","journal-title":"Jpn J Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.4049\/jimmunol.1700003","article-title":"Antigen-presenting human γδ T cells promote intestinal CD4(+) T cell expression of IL-22 and mucosal release of calprotectin","volume":"198","author":"Tyler","year":"2017","unstructured":"Tyler CJ, McCarthy NE, Lindsay JO, Stagg AJ, Moser B and Eberl M. Antigen-presenting human γδ T cells promote intestinal CD4(+) T cell expression of IL-22 and mucosal release of calprotectin. J Immunol 2017; 198: 3417-3425.","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gammadelta T cells","volume":"309","author":"Brandes","year":"2005","unstructured":"Brandes M, Willimann K and Moser B. Professional antigen-presentation function by human gammadelta T cells. Science 2005; 309: 264-268.","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40425-019-0501-8","article-title":"Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma","volume":"7","author":"Alnaggar","year":"2019","unstructured":"Alnaggar M, Xu Y, Li J, He J, Chen J, Li M, Wu Q, Lin L, Liang Y, Wang X, Li J, Hu Y, Chen Y, Xu K, Wu Y and Yin Z. Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. J Immunother Cancer 2019; 7: 36.","journal-title":"J Immunother Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ibd\/izaa121","article-title":"Retinoic acid is elevated in the mucosa of patients with active ulcerative colitis and displays a proinflammatory role by augmenting IL-17 and IFNγ production","volume":"27","author":"Rampal","year":"2021","unstructured":"Rampal R, Wari N, Singh AK, Das U, Bopanna S, Gupta V, Nayak B, Velapandian T, Kedia S, Kumar D, Awasthi A and Ahuja V. Retinoic acid is elevated in the mucosa of patients with active ulcerative colitis and displays a proinflammatory role by augmenting IL-17 and IFNγ production. Inflamm Bowel Dis 2021; 27: 74-83.","journal-title":"Inflamm Bowel Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/gutjnl-2020-322101","article-title":"Characterisation of γδ T cells infiltrating colorectal cancer","volume":"70","author":"Lo Presti","year":"2021","unstructured":"Lo Presti E, Corsale AM, Di Simone M, Dieli F and Meraviglia S. Characterisation of γδ T cells infiltrating colorectal cancer. Gut 2021; 70: 1001-1003.","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Wu Y, Kyle-Cezar F, Woolf RT, Naceur-Lombardelli C, Owen J, Biswas D, Lorenc A, Vantourout P, Gazinska P, Grigoriadis A, Tutt A and Hayday A. An innate-like Vδ1(+) γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci Transl Med 2019; 11: eaax9364.","DOI":"10.1126\/scitranslmed.aax9364"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/ijc.34669","article-title":"Tumor-infiltrating gamma delta T-cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer","volume":"153","author":"Yu","year":"2023","unstructured":"Yu L, Wang Z, Hu Y, Wang Y, Lu N and Zhang C. Tumor-infiltrating gamma delta T-cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer. Int J Cancer 2023; 153: 1684-1697.","journal-title":"Int J Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4049\/jimmunol.1300121","article-title":"Cutting edge: CD1d restriction and Th1\/Th2\/Th17 cytokine secretion by human Vδ3 T cells","volume":"191","author":"BA","year":"2013","unstructured":"Mangan BA, Dunne MR, O’Reilly VP, Dunne PJ, Exley MA, O’Shea D, Scotet E, Hogan AE and Doherty DG. Cutting edge: CD1d restriction and Th1\/Th2\/Th17 cytokine secretion by human Vδ3 T cells. J Immunol 2013; 191: 30-34.","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molimm.2021.06.006","article-title":"Differentiation and functional plasticity of gamma-delta (γδ) T cells under homeostatic and disease conditions","volume":"136","author":"Giri","year":"2021","unstructured":"Giri S and Lal G. Differentiation and functional plasticity of gamma-delta (γδ) T cells under homeostatic and disease conditions. Mol Immunol 2021; 136: 138-149.","journal-title":"Mol Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"573920","DOI":"10.3389\/fimmu.2020.573920","article-title":"High abundance of intratumoral γδ T cells favors a better prognosis in head and neck squamous cell carcinoma: a bioinformatic analysis","volume":"11","author":"Lu","year":"2020","unstructured":"Lu H, Dai W, Guo J, Wang D, Wen S, Yang L, Lin D, Xie W, Wen L, Fang J and Wang Z. High abundance of intratumoral γδ T cells favors a better prognosis in head and neck squamous cell carcinoma: a bioinformatic analysis. Front Immunol 2020; 11: 573920.","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/cmi.2012.45","article-title":"Diversity of γδ T-cell antigens","volume":"10","author":"WK","year":"2013","unstructured":"Born WK, Kemal Aydintug M and O’Brien RL. Diversity of γδ T-cell antigens. Cell Mol Immunol 2013; 10: 13-20.","journal-title":"Cell Mol Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41577-018-0007-5","article-title":"Understanding the drivers of MHC restriction of T cell receptors","volume":"18","author":"La Gruta","year":"2018","unstructured":"La Gruta NL, Gras S, Daley SR, Thomas PG and Rossjohn J. Understanding the drivers of MHC restriction of T cell receptors. Nat Rev Immunol 2018; 18: 467-478.","journal-title":"Nat Rev Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/cells9051305","article-title":"γδ T cells: the ideal tool for cancer immunotherapy","volume":"9","author":"Yazdanifar","year":"2020","unstructured":"Yazdanifar M, Barbarito G, Bertaina A and Airoldi I. γδ T cells: the ideal tool for cancer immunotherapy. Cells 2020; 9: 1305.","journal-title":"Cells"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Rigau M, Ostrouska S, Fulford TS, Johnson DN, Woods K, Ruan Z, McWilliam HEG, Hudson C, Tutuka C, Wheatley AK, Kent SJ, Villadangos JA, Pal B, Kurts C, Simmonds J, Pelzing M, Nash AD, Hammet A, Verhagen AM, Vairo G, Maraskovsky E, Panousis C, Gherardin NA, Cebon J, Godfrey DI, Behren A and Uldrich AP. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Science 2020; 367: eaay5516.","DOI":"10.1126\/science.aay5516"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1073\/pnas.1015433108","article-title":"Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA","volume":"108","author":"Xu","year":"2011","unstructured":"Xu B, Pizarro JC, Holmes MA, McBeth C, Groh V, Spies T and Strong RK. Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA. Proc Natl Acad Sci U S A 2011; 108: 2414-2419.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"625165","DOI":"10.3389\/fimmu.2021.625165","article-title":"Granulocyte colony-stimulating factor effectively mobilizes TCR γδ and NK cells providing an allograft potentially enhanced for the graft-versus-leukemia effect for allogeneic stem cell transplantation","volume":"12","author":"Minculescu","year":"2021","unstructured":"Minculescu L, Sengelov H, Marquart HV, Ryder LP, Fischer-Nielsen A and Haastrup E. Granulocyte colony-stimulating factor effectively mobilizes TCR γδ and NK cells providing an allograft potentially enhanced for the graft-versus-leukemia effect for allogeneic stem cell transplantation. Front Immunol 2021; 12: 625165.","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2019.04.006","article-title":"Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients","volume":"203","author":"Wang","year":"2019","unstructured":"Wang X, Mou W, Han W, Xi Y, Chen X, Zhang H, Qin H, Wang H, Ma X and Gui J. Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients. Clin Immunol 2019; 203: 63-71.","journal-title":"Clin Immunol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12865-015-0124-x","article-title":"In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells","volume":"16","author":"Niu","year":"2015","unstructured":"Niu C, Jin H, Li M, Xu J, Xu D, Hu J, He H, Li W and Cui J. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells. BMC Immunol 2015; 16: 61.","journal-title":"BMC Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer","volume":"19","author":"Silva-Santos B","year":"2019","unstructured":"Silva-Santos B, Mensurado S and Coffelt SB. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer 2019; 19: 392-404.","journal-title":"Nat Rev Cancer"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.xcrm.2023.100961","article-title":"A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies","volume":"4","author":"Lameris","year":"2023","unstructured":"Lameris R, Ruben JM, Iglesias-Guimarais V, de Jong M, Veth M, van de Bovenkamp FS, de Weerdt I, Kater AP, Zweegman S, Horbach S, Riedl T, Winograd B, Roovers RC, Adang AEP, de Gruijl TD, Parren PWHI and van der Vliet HJ. A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies. Cell Rep Med 2023; 4: 100961.","journal-title":"Cell Rep Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fimmu.2017.01401","article-title":"Current advances in γδ T cell-based tumor immunotherapy","volume":"8","author":"Lo Presti","year":"2017","unstructured":"Lo Presti E, Pizzolato G, Gulotta E, Cocorullo G, Gulotta G, Dieli F and Meraviglia S. Current advances in γδ T cell-based tumor immunotherapy. Front Immunol 2017; 8: 1401.","journal-title":"Front Immunol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1007\/s00018-017-2583-0","article-title":"Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens","volume":"74","author":"Moulin","year":"2017","unstructured":"Moulin M, Alguacil J, Gu S, Mehtougui A, Adams EJ, Peyrottes S and Champagne E. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens. Cell Mol Life Sci 2017; 74: 4353-4367.","journal-title":"Cell Mol Life Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/2326-6066.CIR-17-0327","article-title":"Low-density lipoprotein uptake inhibits the activation and antitumor functions of human Vγ9Vδ2 T cells","volume":"6","author":"NV","year":"2018","unstructured":"Rodrigues NV, Correia DV, Mensurado S, Nóbrega-Pereira S, deBarros A, Kyle-Cezar F, Tutt A, Hayday AC, Norell H, Silva-Santos B and Dias S. Low-density lipoprotein uptake inhibits the activation and antitumor functions of human Vγ9Vδ2 T cells. Cancer Immunol Res 2018; 6: 448-457.","journal-title":"Cancer Immunol Res"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Chitadze G, Lettau M, Luecke S, Wang T, Janssen O, Fürst D, Mytilineos J, Wesch D, Oberg HH, Held-Feindt J and Kabelitz D. NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors. Oncoimmunology 2016; 5: e1093276.","DOI":"10.1080\/2162402X.2015.1093276"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"16347","DOI":"10.1038\/s41598-021-95908-5","article-title":"Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production","volume":"11","author":"Alice","year":"2021","unstructured":"Alice AF, Kramer G, Bambina S, Bahjat KS, Gough MJ and Crittenden MR. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production. Sci Rep 2021; 11: 16347.","journal-title":"Sci Rep"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","unstructured":"Corvaisier M, Moreau-Aubry A, Diez E, Bennouna J, Mosnier JF, Scotet E, Bonneville M and Jotereau F. V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol 2005; 175: 5481-5488.","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Dar AA, Patil RS and Chiplunkar SV. Insights into the relationship between toll like receptors and gamma delta T cell responses. Front Immunol 2014; 5: 366.","DOI":"10.3389\/fimmu.2014.00366"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2010.05.005","article-title":"Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: a new approach","volume":"297","author":"Dokouhaki","year":"2010","unstructured":"Dokouhaki P, Han M, Joe B, Li M, Johnston MR, Tsao MS and Zhang L. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: a new approach. Cancer Lett 2010; 297: 126-136.","journal-title":"Cancer Lett"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/cells9081757","article-title":"Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on γδ T and NK cells","volume":"9","author":"Morandi","year":"2020","unstructured":"Morandi F, Yazdanifar M, Cocco C, Bertaina A and Airoldi I. Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on γδ T and NK cells. Cells 2020; 9: 1757.","journal-title":"Cells"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Tosolini M, Pont F, Poupot M, Vergez F, Nicolau-Travers ML, Vermijlen D, Sarry JE, Dieli F and Fournié JJ. Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays. Oncoimmunology 2017; 6: e1284723.","DOI":"10.1080\/2162402X.2017.1284723"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fimmu.2013.00069","article-title":"Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells","volume":"4","author":"Hudspeth","year":"2013","unstructured":"Hudspeth K, Silva-Santos B and Mavilio D. Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front Immunol 2013; 4: 69.","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/cancers12010130","article-title":"In the absence of a TCR signal IL-2\/IL-12\/18-stimulated γδ T cells demonstrate potent anti-tumoral function through direct killing and senescence induction in cancer cells","volume":"12","author":"Schilbach","year":"2020","unstructured":"Schilbach K, Welker C, Krickeberg N, Kaißer C, Schleicher S and Hashimoto H. In the absence of a TCR signal IL-2\/IL-12\/18-stimulated γδ T cells demonstrate potent anti-tumoral function through direct killing and senescence induction in cancer cells. Cancers (Basel) 2020; 12: 130.","journal-title":"Cancers (Basel)"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Zhao Y, Niu C and Cui J. Gamma-delta (γδ) T cells: friend or foe in cancer development? J Transl Med 2018; 16: 3.","DOI":"10.1186\/s12967-017-1378-2"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Feng N, Luo JM and Guo X. The immune influence of a parabiosis model on tumour-bearing mice. Swiss Med Wkly 2018; 148: w14678.","DOI":"10.4414\/smw.2018.14678"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00262-019-02379-9","article-title":"A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice","volume":"68","author":"Xu","year":"2019","unstructured":"Xu Y, Zhang X, Wang Y, Pan M, Wang M and Zhang J. A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice. Cancer Immunol Immunother 2019; 68: 1429-1441.","journal-title":"Cancer Immunol Immunother"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1182\/blood-2011-11-390153","article-title":"Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication","volume":"119","author":"Hudspeth","year":"2012","unstructured":"Hudspeth K, Fogli M, Correia DV, Mikulak J, Roberto A, Della Bella S, Silva-Santos B and Mavilio D. Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood 2012; 119: 4013-4016.","journal-title":"Blood"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Lee HW, Chung YS and Kim TJ. Heterogeneity of human γδ T cells and their role in cancer immunity. Immune Netw 2020; 20: e5.","DOI":"10.4110\/in.2020.20.e5"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","unstructured":"Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, Sainson R, Jovanovic J, Tigue NJ, Bannister D, Bamber L, Valge-Archer V and Wilkinson RW. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer 2017; 116: 1208-1217.","journal-title":"Br J Cancer"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","article-title":"γδ T cells are effectors of immunotherapy in cancers with HLA class I defects","volume":"613","author":"de Vries","year":"2023","unstructured":"de Vries NL, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn ME, van der Ploeg M, van den Bulk J, Ruano D, van den Berg JG, Haanen JB, Zeverijn LJ, Geurts BS, de Wit GF, Battaglia TW, Gelderblom H, Verheul HMW, Schumacher TN, Wessels LFA, Koning F, de Miranda NFCC and Voest EE. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 2023; 613: 743-750.","journal-title":"Nature"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.4049\/jimmunol.168.10.4920","article-title":"Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2\/V gamma 9 gamma delta T cells","volume":"168","author":"Glatzel","year":"2002","unstructured":"Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O and Kabelitz D. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2\/V gamma 9 gamma delta T cells. J Immunol 2002; 168: 4920-4929.","journal-title":"J Immunol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3389\/fimmu.2020.01396","article-title":"Vγ9Vδ2 T cells activation through phosphoantigens can be impaired by a RHOB rerouting in lung cancer","volume":"11","author":"Laplagne","year":"2020","unstructured":"Laplagne C, Meddour S, Figarol S, Michelas M, Calvayrac O, Favre G, Laurent C, Fournié JJ, Cabantous S and Poupot M. Vγ9Vδ2 T cells activation through phosphoantigens can be impaired by a RHOB rerouting in lung cancer. Front Immunol 2020; 11: 1396.","journal-title":"Front Immunol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/cells9061433","article-title":"An update on the molecular basis of phosphoantigen recognition by Vγ9Vδ2 T cells","volume":"9","author":"Herrmann","year":"2020","unstructured":"Herrmann T, Fichtner AS and Karunakaran MM. An update on the molecular basis of phosphoantigen recognition by Vγ9Vδ2 T cells. Cells 2020; 9: 1433.","journal-title":"Cells"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s12276-023-00985-3","article-title":"Double-edged sword: γδ T cells in mucosal homeostasis and disease","volume":"55","author":"Kang","year":"2023","unstructured":"Kang I, Kim Y and Lee HK. Double-edged sword: γδ T cells in mucosal homeostasis and disease. Exp Mol Med 2023; 55: 1895-1904.","journal-title":"Exp Mol Med"},{"key":"ref71","unstructured":"Murayama M, Tanaka Y, Yagi J, Uchiyama T and Ogawa K. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas. Anticancer Res 2008; 28: 2921-2931."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4419-1050-9_2","article-title":"Activation of γδ T cells by bisphosphonates","volume":"658","author":"Thompson","year":"2010","unstructured":"Thompson K, Roelofs AJ, Jauhiainen M, Mönkkönen H, Mönkkönen J and Rogers MJ. Activation of γδ T cells by bisphosphonates. Adv Exp Med Biol 2010; 658: 11-20.","journal-title":"Adv Exp Med Biol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"312","DOI":"10.12691\/jfnr-2-6-8","article-title":"Effect of ultrasound treatment prior to vacuum and modified atmosphere packaging on microbial and physical characteristics of fresh beef","volume":"2","author":"Abdalhai","year":"2014","unstructured":"Abdalhai MH, Bashari M, Lagnika C, He Q and Sun X. Effect of ultrasound treatment prior to vacuum and modified atmosphere packaging on microbial and physical characteristics of fresh beef. J Food Nutr Res 2014; 2: 312-320.","journal-title":"J Food Nutr Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fimmu.2014.00607","article-title":"Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance, and differential programing in the tumor microenvironment","volume":"5","author":"Presti E","year":"2014","unstructured":"Lo Presti E, Dieli F and Meraviglia S. Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance, and differential programing in the tumor microenvironment. Front Immunol 2014; 5: 607.","journal-title":"Front Immunol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC and Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 2015; 15: 388-400.","journal-title":"Nat Rev Immunol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3389\/fimmu.2018.00998","article-title":"Zoledronate triggers Vδ2 T cells to destroy and kill spheroids of colon carcinoma: quantitative image analysis of three-dimensional cultures","volume":"9","author":"Varesano","year":"2018","unstructured":"Varesano S, Zocchi MR and Poggi A. Zoledronate triggers Vδ2 T cells to destroy and kill spheroids of colon carcinoma: quantitative image analysis of three-dimensional cultures. Front Immunol 2018; 9: 998.","journal-title":"Front Immunol"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, Catalano V, Stassi G, Cicero G, Vieni S, Fourniè JJ and Dieli F. Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. Oncoimmunology 2017; 6: e1347742.","DOI":"10.1080\/2162402X.2017.1347742"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.18632\/oncotarget.13051","article-title":"γδ T cells in cancer immunotherapy","volume":"8","author":"Zou","year":"2017","unstructured":"Zou C, Zhao P, Xiao Z, Han X, Fu F and Fu L. γδ T cells in cancer immunotherapy. Oncotarget 2017; 8: 8900-8909.","journal-title":"Oncotarget"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/phrs.1997.0130","article-title":"Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3’-azido-3’-deoxythymidine","volume":"35","author":"Giuliani","year":"1997","unstructured":"Giuliani A, Tentori L, Pepponi R, Porcelli SA, Aquino A, Orlando L, Sugita M, Brenner MB, Bonmassar E and Graziani G. Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3’-azido-3’-deoxythymidine. Pharmacol Res 1997; 35: 135-140.","journal-title":"Pharmacol Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"619954","DOI":"10.3389\/fimmu.2020.619954","article-title":"The dual roles of human γδ T cells: anti-tumor or tumor-promoting","volume":"11","author":"Li","year":"2021","unstructured":"Li Y, Li G, Zhang J, Wu X and Chen X. The dual roles of human γδ T cells: anti-tumor or tumor-promoting. Front Immunol 2021; 11: 619954.","journal-title":"Front Immunol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fimmu.2014.00575","article-title":"γδ T lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy","volume":"5","author":"Poggi","year":"2014","unstructured":"Poggi A and Zocchi MR. γδ T lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy. Front Immunol 2014; 5: 575.","journal-title":"Front Immunol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","article-title":"Cancer immunotherapy with γδ T cells: many paths ahead of us","volume":"17","author":"Kabelitz","year":"2020","unstructured":"Kabelitz D, Serrano R, Kouakanou L, Peters C and Kalyan S. Cancer immunotherapy with γδ T cells: many paths ahead of us. Cell Mol Immunol 2020; 17: 925-939.","journal-title":"Cell Mol Immunol"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Wu D, Wu P, Wu X, Ye J, Wang Z, Zhao S, Ni C, Hu G, Xu J, Han Y, Zhang T, Qiu F, Yan J and Huang J. Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer. Oncoimmunology 2015; 4: e992749.","DOI":"10.4161\/2162402X.2014.992749"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3389\/fimmu.2018.00984","article-title":"Human γδ T-cells: from surface receptors to the therapy of high-risk leukemias","volume":"9","author":"Pistoia","year":"2018","unstructured":"Pistoia V, Tumino N, Vacca P, Veneziani I, Moretta A, Locatelli F and Moretta L. Human γδ T-cells: from surface receptors to the therapy of high-risk leukemias. Front Immunol 2018; 9: 984.","journal-title":"Front Immunol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-0899-7","article-title":"Interleukin-22 protects intestinal stem cells against genotoxic stress","volume":"566","author":"Gronke","year":"2019","unstructured":"Gronke K, Hernández PP, Zimmermann J, Klose CSN, Kofoed-Branzk M, Guendel F, Witkowski M, Tizian C, Amann L, Schumacher F, Glatt H, Triantafyllopoulou A and Diefenbach A. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature 2019; 566: 249-253.","journal-title":"Nature"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Bruni E, Cimino MM, Donadon M, Carriero R, Terzoli S, Piazza R, Ravens S, Prinz I, Cazzetta V, Marzano P, Kunderfranco P, Peano C, Soldani C, Franceschini B, Colombo FS, Garlanda C, Mantovani A, Torzilli G, Mikulak J and Mavilio D. Intrahepatic CD69(+)Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression. J Immunother Cancer 2022; 10: e004579.","DOI":"10.1136\/jitc-2022-004579"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Guzik TJ, Nosalski R, Maffia P and Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol 2024; [Epub ahead of print].","DOI":"10.1038\/s41569-023-00964-1"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.abj8695","article-title":"TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets","volume":"377","author":"Reis","year":"2022","unstructured":"Reis BS, Darcy PW, Khan IZ, Moon CS, Kornberg AE, Schneider VS, Alvarez Y, Eleso O, Zhu C, Schernthanner M, Lockhart A, Reed A, Bortolatto J, Castro TBR, Bilate AM, Grivennikov S, Han AS and Mucida D. TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets. Science 2022; 377: 276-284.","journal-title":"Science"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Van Hede D, Polese B, Humblet C, Wilharm A, Renoux V, Dortu E, de Leval L, Delvenne P, Desmet CJ, Bureau F, Vermijlen D and Jacobs N. Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation. Proc Natl Acad Sci U S A 2017; 114: E9056-E9065.","DOI":"10.1073\/pnas.1712883114"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.trecan.2017.06.003","article-title":"γδ T cells: unexpected regulators of cancer development and progression","volume":"3","author":"Fleming","year":"2017","unstructured":"Fleming C, Morrissey S, Cai Y and Yan J. γδ T cells: unexpected regulators of cancer development and progression. Trends Cancer 2017; 3: 561-570.","journal-title":"Trends Cancer"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/jcp.30655","article-title":"The PI3K\/Akt\/mTOR axis in colorectal cancer: oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles","volume":"237","author":"Sanaei","year":"2022","unstructured":"Sanaei MJ, Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Shahrokh S, Zali MR and Bashash D. The PI3K\/Akt\/mTOR axis in colorectal cancer: oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. J Cell Physiol 2022; 237: 1720-1752.","journal-title":"J Cell Physiol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/jcmm.13938","article-title":"IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K\/AKT signalling pathway","volume":"23","author":"Zheng","year":"2019","unstructured":"Zheng Q, Diao S, Wang Q, Zhu C, Sun X, Yin B, Zhang X, Meng X and Wang B. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K\/AKT signalling pathway. J Cell Mol Med 2019; 23: 357-369.","journal-title":"J Cell Mol Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","unstructured":"Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J, Zhang W, Zhong Z, Sanchez-Lopez E, Wu LW, Taniguchi K, Feng Y, Fearon E, Grivennikov SI and Karin M. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 2014; 41: 1052-1063.","journal-title":"Immunity"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nri3904","article-title":"γδ T cells in cancer","volume":"15","author":"Silva-Santos B","year":"2015","unstructured":"Silva-Santos B, Serre K and Norell H. γδ T cells in cancer. Nat Rev Immunol 2015; 15: 683-691.","journal-title":"Nat Rev Immunol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","article-title":"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses","volume":"15","author":"Wu","year":"2009","unstructured":"Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM and Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022.","journal-title":"Nat Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fimmu.2020.00108","article-title":"IL-17A modulates peritoneal macrophage recruitment and M2 polarization in endometriosis","volume":"11","author":"Miller","year":"2020","unstructured":"Miller JE, Ahn SH, Marks RM, Monsanto SP, Fazleabas AT, Koti M and Tayade C. IL-17A modulates peritoneal macrophage recruitment and M2 polarization in endometriosis. Front Immunol 2020; 11: 108.","journal-title":"Front Immunol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.3390\/cancers13246212","article-title":"The diverse roles of γδ T cells in cancer: from rapid immunity to aggressive lymphoma","volume":"13","author":"Sch&#xF6","year":"2021","unstructured":"Schönefeldt S, Wais T, Herling M, Mustjoki S, Bekiaris V, Moriggl R and Neubauer HA. The diverse roles of γδ T cells in cancer: from rapid immunity to aggressive lymphoma. Cancers (Basel) 2021; 13: 6212.","journal-title":"Cancers (Basel)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.4049\/jimmunol.1202369","article-title":"Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence","volume":"190","author":"Ye","year":"2013","unstructured":"Ye J, Ma C, Hsueh EC, Eickhoff CS, Zhang Y, Varvares MA, Hoft DF and Peng G. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. J Immunol 2013; 190: 2403-2414.","journal-title":"J Immunol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/JLB.5MR0722-777R","article-title":"γδ T cell exhaustion: opportunities for intervention","volume":"112","author":"Chen","year":"2022","unstructured":"[100] Chen D, Guo Y, Jiang J, Wu P, Zhang T, Wei Q, Huang J and Wu D. γδ T cell exhaustion: opportunities for intervention. J Leukoc Biol 2022; 112: 1669-1676.","journal-title":"J Leukoc Biol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.trsl.2018.08.005","article-title":"The role of gamma delta T lymphocytes in breast cancer: a review","volume":"203","author":"ES","year":"2019","unstructured":"[101] Morrow ES, Roseweir A and Edwards J. The role of gamma delta T lymphocytes in breast cancer: a review. Transl Res 2019; 203: 88-96.","journal-title":"Transl Res"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fimmu.2017.01041","article-title":"Dual face of Vγ9Vδ2-T cells in tumor immunology: anti- versus pro-tumoral activities","volume":"8","author":"Xiang","year":"2017","unstructured":"[102] Xiang Z and Tu W. Dual face of Vγ9Vδ2-T cells in tumor immunology: anti- versus pro-tumoral activities. Front Immunol 2017; 8: 1041.","journal-title":"Front Immunol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/eji.200940157","article-title":"Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis","volume":"40","author":"Wakita","year":"2010","unstructured":"[103] Wakita D, Sumida K, Iwakura Y, Nishikawa H, Ohkuri T, Chamoto K, Kitamura H and Nishimura T. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol 2010; 40: 1927-1937.","journal-title":"Eur J Immunol"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"[104] Andreu-Ballester JC, Galindo-Regal L, Hidalgo-Coloma J, Cuéllar C, García-Ballesteros C, Hurtado C, Uribe N, Del Carmen Martín M, Jiménez AI, López-Chuliá F and Llombart-Cussac A. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors. PLoS One 2020; 15: e0243545.","DOI":"10.1371\/journal.pone.0243545"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.celrep.2017.05.071","article-title":"Strong TCRγδ signaling prohibits thymic development of IL-17A-secreting γδ T cells","volume":"19","author":"Sumaria","year":"2017","unstructured":"[105] Sumaria N, Grandjean CL, Silva-Santos B and Pennington DJ. Strong TCRγδ signaling prohibits thymic development of IL-17A-secreting γδ T cells. Cell Rep 2017; 19: 2469-2476.","journal-title":"Cell Rep"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2012.12.015","article-title":"The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner","volume":"58","author":"Yi","year":"2013","unstructured":"[106] Yi Y, He HW, Wang JX, Cai XY, Li YW, Zhou J, Cheng YF, Jin JJ, Fan J and Qiu SJ. The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner. J Hepatol 2013; 58: 977-983.","journal-title":"J Hepatol"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"[107] Hu G, Wu P, Cheng P, Zhang Z, Wang Z, Yu X, Shao X, Wu D, Ye J, Zhang T, Wang X, Qiu F, Yan J and Huang J. Tumor-infiltrating CD39(+)γδ Tregs are novel immunosuppressive T cells in human colorectal cancer. Oncoimmunology 2017; 6: e1277305.","DOI":"10.1080\/2162402X.2016.1277305"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/JLB.5MA0320-201RR","article-title":"Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer","volume":"108","author":"Lo Presti","year":"2020","unstructured":"[108] Lo Presti E, Mocciaro F, Mitri RD, Corsale AM, Di Simone M, Vieni S, Scibetta N, Unti E, Dieli F and Meraviglia S. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer. J Leukoc Biol 2020; 108: 749-760.","journal-title":"J Leukoc Biol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12967-019-1897-0","article-title":"Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment","volume":"17","author":"Chen","year":"2019","unstructured":"[109] Chen X, Shang W, Xu R, Wu M, Zhang X, Huang P, Wang F and Pan S. Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment. J Transl Med 2019; 17: 144.","journal-title":"J Transl Med"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"[110] Zhan Y, Zheng L, Liu J, Hu D, Wang J, Liu K, Guo J, Zhang T and Kong D. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization. JCI Insight 2021; 6: e148028.","DOI":"10.1172\/jci.insight.148028"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells","volume":"71","author":"Peters","year":"2014","unstructured":"[111] Peters C, Oberg HH, Kabelitz D and Wesch D. Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells. Cell Mol Life Sci 2014; 71: 1943-1960.","journal-title":"Cell Mol Life Sci"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3389\/fimmu.2018.01395","article-title":"γδ T cells and tumor microenvironment: from immunosurveillance to tumor evasion","volume":"9","author":"Lo Presti","year":"2018","unstructured":"[112] Lo Presti E, Pizzolato G, Corsale AM, Caccamo N, Sireci G, Dieli F and Meraviglia S. γδ T cells and tumor microenvironment: from immunosurveillance to tumor evasion. Front Immunol 2018; 9: 1395.","journal-title":"Front Immunol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"894315","DOI":"10.3389\/fimmu.2022.894315","article-title":"γδ T cells in the tumor microenvironment-interactions with other immune cells","volume":"13","author":"Chan","year":"2022","unstructured":"[113] Chan KF, Duarte JDG, Ostrouska S and Behren A. γδ T cells in the tumor microenvironment-interactions with other immune cells. Front Immunol 2022; 13: 894315.","journal-title":"Front Immunol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.4049\/jimmunol.1300434","article-title":"Protective role of the inflammatory CCR2\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds","volume":"190","author":"Lan&#xE7","year":"2013","unstructured":"[114] Lança T, Costa MF, Gonçalves-Sousa N, Rei M, Grosso AR, Penido C and Silva-Santos B. Protective role of the inflammatory CCR2\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds. J Immunol 2013; 190: 6673-6680.","journal-title":"J Immunol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-030-49270-0_5","article-title":"γδ T cells in tumor microenvironment","volume":"1273","author":"Imbert","year":"2020","unstructured":"[115] Imbert C and Olive D. γδ T cells in tumor microenvironment. Adv Exp Med Biol 2020; 1273: 91-104.","journal-title":"Adv Exp Med Biol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/bs.mie.2019.07.019","article-title":"In vitro expansion of Vγ9Vδ2 T cells for immunotherapy","volume":"631","author":"Peters","year":"2020","unstructured":"[116] Peters C, Kouakanou L, Oberg HH, Wesch D and Kabelitz D. In vitro expansion of Vγ9Vδ2 T cells for immunotherapy. Methods Enzymol 2020; 631: 223-237.","journal-title":"Methods Enzymol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","article-title":"Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept","volume":"22","author":"Almeida","year":"2016","unstructured":"[117] Almeida AR, Correia DV, Fernandes-Platzgummer A, da Silva CL, da Silva MG, Anjos DR and Silva-Santos B. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept. Clin Cancer Res 2016; 22: 5795-5804.","journal-title":"Clin Cancer Res"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/2326-6066.CIR-18-0647","article-title":"Broad cytotoxic targeting of acute myeloid leukemia by polyclonal delta one T cells","volume":"7","author":"Lorenzo B","year":"2019","unstructured":"[118] Di Lorenzo B, Simões AE, Caiado F, Tieppo P, Correia DV, Carvalho T, da Silva MG, Déchanet-Merville J, Schumacher TN, Prinz I, Norell H, Ravens S, Vermijlen D and Silva-Santos B. Broad cytotoxic targeting of acute myeloid leukemia by polyclonal delta one T cells. Cancer Immunol Res 2019; 7: 552-558.","journal-title":"Cancer Immunol Res"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/cmi.2016.55","article-title":"Human γδT-cell subsets and their involvement in tumor immunity","volume":"14","author":"Wu","year":"2017","unstructured":"[119] Wu D, Wu P, Qiu F, Wei Q and Huang J. Human γδT-cell subsets and their involvement in tumor immunity. Cell Mol Immunol 2017; 14: 245-253.","journal-title":"Cell Mol Immunol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.omto.2020.04.013","article-title":"Electroporation of NKG2D RNA CAR improves Vγ9Vδ2 T cell responses against human solid tumor xenografts","volume":"17","author":"Ang","year":"2020","unstructured":"[120] Ang WX, Ng YY, Xiao L, Chen C, Li Z, Chi Z, Tay JC, Tan WK, Zeng J, Toh HC and Wang S. Electroporation of NKG2D RNA CAR improves Vγ9Vδ2 T cell responses against human solid tumor xenografts. Mol Ther Oncolytics 2020; 17: 421-430.","journal-title":"Mol Ther Oncolytics"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/cancers15041264","article-title":"NKG2A immune checkpoint in Vδ2 T cells: emerging application in cancer immunotherapy","volume":"15","author":"Cazzetta","year":"2023","unstructured":"[121] Cazzetta V, Depierreux D, Colucci F, Mikulak J and Mavilio D. NKG2A immune checkpoint in Vδ2 T cells: emerging application in cancer immunotherapy. Cancers (Basel) 2023; 15: 1264.","journal-title":"Cancers (Basel)"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"[122] Pressey JG, Adams J, Harkins L, Kelly D, You Z and Lamb LS Jr. In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: a phase 1 study. Medicine (Baltimore) 2016; 95: e4909.","DOI":"10.1097\/MD.0000000000004909"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2018.05.002","article-title":"The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy","volume":"41","author":"Van Acker","year":"2018","unstructured":"[123] Van Acker HH, Campillo-Davo D, Roex G, Versteven M, Smits EL and Van Tendeloo VF. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Cytokine Growth Factor Rev 2018; 41: 54-64.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jcyt.2017.12.014","article-title":"Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells","volume":"20","author":"Xiao","year":"2018","unstructured":"[124] Xiao L, Chen C, Li Z, Zhu S, Tay JC, Zhang X, Zha S, Zeng J, Tan WK, Liu X, Chng WJ and Wang S. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells. Cytotherapy 2018; 20: 420-435.","journal-title":"Cytotherapy"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00262-010-0879-0","article-title":"Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors","volume":"59","author":"Bennouna","year":"2010","unstructured":"[125] Bennouna J, Levy V, Sicard H, Senellart H, Audrain M, Hiret S, Rolland F, Bruzzoni-Giovanelli H, Rimbert M, Galéa C, Tiollier J and Calvo F. Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Cancer Immunol Immunother 2010; 59: 1521-1530.","journal-title":"Cancer Immunol Immunother"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","unstructured":"[126] Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, La Mendola C, Guggino G, D’Asaro M, Orlando V, Scarpa F, Roberts A, Caccamo N, Stassi G, Dieli F and Hayday AC. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 2010; 161: 290-297.","journal-title":"Clin Exp Immunol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3389\/fimmu.2020.01405","article-title":"Comparison of a novel bisphosphonate prodrug and zoledronic acid in the induction of cytotoxicity in human Vgamma2Vdelta2 T cells","volume":"11","author":"Okuno","year":"2020","unstructured":"[127] Okuno D, Sugiura Y, Sakamoto N, Tagod MSO, Iwasaki M, Noda S, Tamura A, Senju H, Umeyama Y, Yamaguchi H, Suematsu M, Morita CT, Tanaka Y and Mukae H. Comparison of a novel bisphosphonate prodrug and zoledronic acid in the induction of cytotoxicity in human Vgamma2Vdelta2 T cells. Front Immunol 2020; 11: 1405.","journal-title":"Front Immunol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.4049\/jimmunol.0804288","article-title":"Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes","volume":"182","author":"Todaro","year":"2009","unstructured":"[128] Todaro M, D’Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F and Stassi G. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 2009; 182: 7287-7296.","journal-title":"J Immunol"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"[129] Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A and Poggi A. Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity. Oncoimmunology 2017; 6: e1278099.","DOI":"10.1080\/2162402X.2016.1278099"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00262-011-1111-6","article-title":"Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens","volume":"61","author":"Altvater","year":"2012","unstructured":"[130] Altvater B, Pscherer S, Landmeier S, Kailayangiri S, Savoldo B, Juergens H and Rossig C. Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens. Cancer Immunol Immunother 2012; 61: 385-396.","journal-title":"Cancer Immunol Immunother"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcyt.2012.12.004","article-title":"Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain","volume":"15","author":"Izumi","year":"2013","unstructured":"[131] Izumi T, Kondo M, Takahashi T, Fujieda N, Kondo A, Tamura N, Murakawa T, Nakajima J, Matsushita H and Kakimi K. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain. Cytotherapy 2013; 15: 481-491.","journal-title":"Cytotherapy"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00262-013-1402-1","article-title":"Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma","volume":"62","author":"Devaud","year":"2013","unstructured":"[132] Devaud C, Rousseau B, Netzer S, Pitard V, Paroissin C, Khairallah C, Costet P, Moreau JF, Couillaud F, Dechanet-Merville J and Capone M. Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma. Cancer Immunol Immunother 2013; 62: 1199-1210.","journal-title":"Cancer Immunol Immunother"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"[133] Nguyen S, Chevalier MF, Benmerzoug S, Cesson V, Schneider AK, Rodrigues-Dias SC, Dartiguenave F, Lucca I, Jichlinski P, Roth B, Nardelli-Haefliger D and Derré L. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments. J Immunother Cancer 2022; 10: e004880.","DOI":"10.1136\/jitc-2022-004880"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"12893","DOI":"10.3390\/ijms241612893","article-title":"Targeting melanoma-associated fibroblasts (MAFs) with activated γδ (Vδ2) T cells: an in vitro cytotoxicity model","volume":"24","author":"Hajdara","year":"2023","unstructured":"[134] Hajdara A, Çakır U, Érsek B, Silló P, Széky B, Barna G, Faqi S, Gyöngy M, Kárpáti S, Németh K and Mayer B. Targeting melanoma-associated fibroblasts (MAFs) with activated γδ (Vδ2) T cells: an in vitro cytotoxicity model. Int J Mol Sci 2023; 24: 12893.","journal-title":"Int J Mol Sci"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/CJI.0000000000000450","article-title":"Haploidentical γδ T cells induce complete remission in chemorefractory B-cell non-Hodgkin lymphoma","volume":"46","author":"Bold","year":"2023","unstructured":"[135] Bold A, Gaertner J, Bott A, Mordstein V, Schaefer-Eckart K and Wilhelm M. Haploidentical γδ T cells induce complete remission in chemorefractory B-cell non-Hodgkin lymphoma. J Immunother 2023; 46: 56-58.","journal-title":"J Immunother"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"[136] Frieling JS, Tordesillas L, Bustos XE, Ramello MC, Bishop RT, Cianne JE, Snedal SA, Li T, Lo CH, de la Iglesia J, Roselli E, Benzaïd I, Wang X, Kim Y, Lynch CC and Abate-Daga D. γδ-enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer. Sci Adv 2023; 9: eadf0108.","DOI":"10.1126\/sciadv.adf0108"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","unstructured":"[137] Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK and Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015; 21: 938-945.","journal-title":"Nat Med"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41423-020-0515-7","article-title":"Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer","volume":"18","author":"Xu","year":"2021","unstructured":"[138] Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He J, Yang J, Hu Y, Chen Y, Lin L, Hao J, Li J, Chen J, Li M, Wu Q, Peters C, Zhou Q, Li J, Liang Y, Wang X, Han B, Ma M, Kabelitz D, Xu K, Tu W, Wu Y and Yin Z. Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cell Mol Immunol 2021; 18: 427-439.","journal-title":"Cell Mol Immunol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","article-title":"Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies","volume":"19","author":"Sebestyen","year":"2020","unstructured":"[139] Sebestyen Z, Prinz I, Déchanet-Merville J, Silva-Santos B and Kuball J. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies. Nat Rev Drug Discov 2020; 19: 169-184.","journal-title":"Nat Rev Drug Discov"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3389\/fimmu.2019.01997","article-title":"-host-disease in patients with high immune reconstitution of TCR gamma delta cells 2 months after allogeneic stem cell transplantation","volume":"10","author":"Minculescu","year":"2019","unstructured":"[140] Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J and Sengelov H. Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of TCR gamma delta cells 2 months after allogeneic stem cell transplantation. Front Immunol 2019; 10: 1997.","journal-title":"Front Immunol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00262-011-1166-4","article-title":"Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes","volume":"61","author":"Lai","year":"2012","unstructured":"[141] Lai D, Wang F, Chen Y, Wang C, Liu S, Lu B, Ge X and Guo L. Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes. Cancer Immunol Immunother 2012; 61: 979-989.","journal-title":"Cancer Immunol Immunother"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10120-011-0138-x","article-title":"Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer","volume":"15","author":"Kuroda","year":"2012","unstructured":"[142] Kuroda H, Saito H and Ikeguchi M. Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer. Gastric Cancer 2012; 15: 433-439.","journal-title":"Gastric Cancer"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","article-title":"Potential for immunotherapy of hepatocellular and colorectal carcinomas","volume":"57","author":"Bouet-Toussaint F","year":"2008","unstructured":"[143] Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K and Catros V. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol Immunother 2008; 57: 531-539.","journal-title":"Cancer Immunol Immunother"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/cam4.196","article-title":"Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer","volume":"3","author":"Wada","year":"2014","unstructured":"[144] Wada I, Matsushita H, Noji S, Mori K, Yamashita H, Nomura S, Shimizu N, Seto Y and Kakimi K. Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer. Cancer Med 2014; 3: 362-375.","journal-title":"Cancer Med"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1182\/blood-2009-08-237123","article-title":"The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia\/lymphoma susceptibility to gammadelta T-cell cytotoxicity","volume":"115","author":"Lan&#xE7","year":"2010","unstructured":"[145] Lança T, Correia DV, Moita CF, Raquel H, Neves-Costa A, Ferreira C, Ramalho JS, Barata JT, Moita LF, Gomes AQ and Silva-Santos B. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia\/lymphoma susceptibility to gammadelta T-cell cytotoxicity. Blood 2010; 115: 2407-2411.","journal-title":"Blood"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bjc.2011.293","article-title":"Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours","volume":"105","author":"Nicol","year":"2011","unstructured":"[146] Nicol AJ, Tokuyama H, Mattarollo SR, Hagi T, Suzuki K, Yokokawa K and Nieda M. Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. Br J Cancer 2011; 105: 778-786.","journal-title":"Br J Cancer"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00262-008-0491-8","article-title":"Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma","volume":"57","author":"Bennouna","year":"2008","unstructured":"[147] Bennouna J, Bompas E, Neidhardt EM, Rolland F, Philip I, Galéa C, Salot S, Saiagh S, Audrain M, Rimbert M, Lafaye-de Micheaux S, Tiollier J and Négrier S. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 2008; 57: 1599-1609.","journal-title":"Cancer Immunol Immunother"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"[148] Lamb LS Jr, Bowersock J, Dasgupta A, Gillespie GY, Su Y, Johnson A and Spencer HT. Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy. PLoS One 2013; 8: e51805.","DOI":"10.1371\/journal.pone.0051805"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/mt.2012.267","article-title":"Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor","volume":"21","author":"Deniger","year":"2013","unstructured":"[149] Deniger DC, Switzer K, Mi T, Maiti S, Hurton L, Singh H, Huls H, Olivares S, Lee DA, Champlin RE and Cooper LJ. Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor. Mol Ther 2013; 21: 638-647.","journal-title":"Mol Ther"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/eji.201040959","article-title":"Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens","volume":"41","author":"Iwasaki","year":"2011","unstructured":"[150] Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M and Minato N. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens. Eur J Immunol 2011; 41: 345-355.","journal-title":"Eur J Immunol"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"111719","DOI":"10.1016\/j.yexcr.2019.111719","article-title":"Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression","volume":"386","author":"Li","year":"2020","unstructured":"[151] Li X, Lu H, Gu Y, Zhang X, Zhang G, Shi T and Chen W. Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression. Exp Cell Res 2020; 386: 111719.","journal-title":"Exp Cell Res"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejca.2016.06.001","article-title":"Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab","volume":"64","author":"Wistuba-Hamprecht","year":"2016","unstructured":"[152] Wistuba-Hamprecht K, Martens A, Haehnel K, Geukes Foppen M, Yuan J, Postow MA, Wong P, Romano E, Khammari A, Dreno B, Capone M, Ascierto PA, Demuth I, Steinhagen-Thiessen E, Larbi A, Schilling B, Schadendorf D, Wolchok JD, Blank CU, Pawelec G, Garbe C and Weide B. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab. Eur J Cancer 2016; 64: 116-126.","journal-title":"Eur J Cancer"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1182\/blood-2012-05-432427","article-title":"γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs","volume":"120","author":"Gr&#xFC","year":"2012","unstructured":"[153] Gründer C, van Dorp S, Hol S, Drent E, Straetemans T, Heijhuurs S, Scholten K, Scheper W, Sebestyen Z, Martens A, Strong R and Kuball J. γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs. Blood 2012; 120: 5153-5162.","journal-title":"Blood"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"[154] de Bruin RCG, Veluchamy JP, Lougheed SM, Schneiders FL, Lopez-Lastra S, Lameris R, Stam AG, Sebestyen Z, Kuball J, Molthoff CFM, Hooijberg E, Roovers RC, Santo JPD, van Bergen En Henegouwen PMP, Verheul HMW, de Gruijl TD and van der Vliet HJ. A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. Oncoimmunology 2017; 7: e1375641.","DOI":"10.1080\/2162402X.2017.1375641"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/0008-5472.CAN-13-0675","article-title":"Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells","volume":"74","author":"HH","year":"2014","unstructured":"[155] Oberg HH, Peipp M, Kellner C, Sebens S, Krause S, Petrick D, Adam-Klages S, Röcken C, Becker T, Vogel I, Weisner D, Freitag-Wolf S, Gramatzki M, Kabelitz D and Wesch D. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells. Cancer Res 2014; 74: 1349-1360.","journal-title":"Cancer Res"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","unstructured":"[156] Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, Zhang T, Chachoua A and Demaria S. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 2018; 24: 1845-1851.","journal-title":"Nat Med"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"[157] Shimizu T, Tomogane M, Miyashita M, Ukimura O and Ashihara E. Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model. Oncoimmunology 2018; 7: e1424671.","DOI":"10.1080\/2162402X.2018.1424671"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"[158] Todaro M, Meraviglia S, Caccamo N, Stassi G and Dieli F. Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. Oncoimmunology 2013; 2: e25821.","DOI":"10.4161\/onci.25821"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"[159] Todaro M, Orlando V, Cicero G, Caccamo N, Meraviglia S, Stassi G and Dieli F. Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity. PLoS One 2013; 8: e65145.","DOI":"10.1371\/journal.pone.0065145"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","unstructured":"[160] Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L, Klapproth K, Schäkel K, Garbi N, Jäger D, Weitz J, Schmitz-Winnenthal H, Hämmerling GJ and Beckhove P. Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013; 24: 589-602.","journal-title":"Cancer Cell"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41423-019-0247-8","article-title":"Vitamin C promotes the proliferation and effector functions of human γδ T cells","volume":"17","author":"Kouakanou","year":"2020","unstructured":"[161] Kouakanou L, Xu Y, Peters C, He J, Wu Y, Yin Z and Kabelitz D. Vitamin C promotes the proliferation and effector functions of human γδ T cells. Cell Mol Immunol 2020; 17: 462-473.","journal-title":"Cell Mol Immunol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/4\/ajcr0155453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:51Z","timestamp":1766022771000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/4\/ajcr0155453.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":161,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/hwmb1163","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}